| 16/03/26 | 07:01:00 | 16 Mar 2026 | | Transaction in Own Shares |
| 16/03/26 | 07:00:13 | 16 Mar 2026 | | Notice of 2025 Annual Results & Webinar |
| 13/03/26 | 07:01:01 | 13 Mar 2026 | | Transaction in Own Shares |
| 13/03/26 | 07:00:06 | 13 Mar 2026 | | Monthly Valuation Update and Factsheet |
| 12/03/26 | 07:00:02 | 12 Mar 2026 | | Transaction in Own Shares |
| 11/03/26 | 07:00:03 | 11 Mar 2026 | | Transaction in Own Shares |
| 13/02/26 | 07:00:04 | 13 Feb 2026 | | Monthly Valuation Update and Factsheet |
| 23/01/26 | 07:00:06 | 23 Jan 2026 | | Corxel completes $287 million Series D-1 financing |
| 22/01/26 | 10:00:00 | 22 Jan 2026 | | Director/PDMR Shareholding |
| 21/01/26 | 07:00:09 | 21 Jan 2026 | | GSK to acquire RAPT Therapeutics |
| 16/01/26 | 07:00:06 | 16 Jan 2026 | | Boston Scientific to acquire Penumbra |
| 15/01/26 | 07:00:07 | 15 Jan 2026 | | Monthly Valuation Update and Factsheet |
| 12/01/26 | 07:00:07 | 12 Jan 2026 | | Aktis announces $318 million IPO |
| 02/01/26 | 07:00:03 | 2 Jan 2026 | | Total Voting Rights |
| 18/12/25 | 07:00:08 | 18 Dec 2025 | | New investment in Yarrow Bioscience |
| 12/12/25 | 07:00:05 | 12 Dec 2025 | | Monthly Valuation Update and Factsheet |
| 10/12/25 | 07:00:05 | 10 Dec 2025 | | Transaction in Own Shares |
| 04/12/25 | 07:00:15 | 4 Dec 2025 | | Inclusion in FTSE 250 Index |
| 02/12/25 | 07:00:03 | 2 Dec 2025 | | Transaction in Own Shares |
| 01/12/25 | 18:00:00 | 1 Dec 2025 | | Spectris |
| 01/12/25 | 07:00:05 | 1 Dec 2025 | | Total Voting Rights |
| 27/11/25 | 07:00:07 | 27 Nov 2025 | | Transaction in Own Shares |
| 26/11/25 | 14:30:01 | 26 Nov 2025 | | Transaction in Own Shares |
| 25/11/25 | 12:00:00 | 25 Nov 2025 | | Retail Investor Webinar |
| 24/11/25 | 07:00:05 | 24 Nov 2025 | | Transaction in Own Shares |
| 21/11/25 | 07:00:06 | 21 Nov 2025 | | Transaction in Own Shares |
| 20/11/25 | 07:00:04 | 20 Nov 2025 | | Transaction in Own Shares |
| 14/11/25 | 07:00:04 | 14 Nov 2025 | | Monthly Valuation Update and Factsheet |
| 07/11/25 | 07:00:10 | 7 Nov 2025 | | Evommune announces $150 million IPO |
| 05/11/25 | 10:00:00 | 5 Nov 2025 | | Holding(s) in Company |
| 03/11/25 | 09:33:52 | 3 Nov 2025 | | Total Voting Rights |
| 31/10/25 | 07:00:08 | 31 Oct 2025 | | Royalty Funding Agreement with Savara Inc. |
| 29/10/25 | 07:00:03 | 29 Oct 2025 | | Transaction in Own Shares |
| 27/10/25 | 07:00:13 | 27 Oct 2025 | | Novartis to acquire Avidity Biosciences |
| 20/10/25 | 07:00:06 | 20 Oct 2025 | | Capital Allocation Plan based on M&A successes |
| 15/10/25 | 07:00:10 | 15 Oct 2025 | | Kailera Therapeutics announces Series B financing |
| 14/10/25 | 07:00:09 | 14 Oct 2025 | | Monthly Valuation Update and Factsheet |
| 10/10/25 | 07:00:09 | 10 Oct 2025 | | Novo Nordisk to acquire Akero Therapeutics |
| 01/10/25 | 07:00:04 | 1 Oct 2025 | | Total Voting Rights |
| 30/09/25 | 07:01:01 | 30 Sept 2025 | | Transaction in Own Shares |
| 30/09/25 | 07:00:28 | 30 Sept 2025 | | Genmab to acquire Merus |
| 29/09/25 | 07:00:06 | 29 Sept 2025 | | Transaction in Own Shares |
| 26/09/25 | 07:00:03 | 26 Sept 2025 | | Transaction in Own Shares |
| 25/09/25 | 07:00:02 | 25 Sept 2025 | | Transaction in Own Shares |
| 24/09/25 | 07:00:05 | 24 Sept 2025 | | Transaction in Own Shares |
| 23/09/25 | 07:01:00 | 23 Sept 2025 | | Transaction in Own Shares |
| 23/09/25 | 07:00:13 | 23 Sept 2025 | | Biogen to acquire Alcyone Therapeutics |
| 15/09/25 | 07:00:13 | 15 Sept 2025 | | Monthly Valuation Update and Factsheet |
| 11/09/25 | 07:00:12 | 11 Sept 2025 | | Half-year Report |
| 05/09/25 | 07:00:02 | 5 Sept 2025 | | Inclusion in FTSE All-Share Index |
